Do arrhythmia patients improve survival by participating in randomized clinical trials? Observations from the Cardiac Arrhythmia Suppression Trial (CAST) and the Antiarrhythmics Versus Implantable Defibrillators Trial (AVID)

Controlled Clinical Trials

Volumn 24, Issue 3, 2003, Pages 341-352

  Hallstrom, Al ^a   Friedman, Lawrence ^b   Denes, Pablo ^c   Rizo Patron, Carlos ^d   Morris, Mary ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Cardiology Associates of Lubbock   (United States)

Author keywords

Enrollees and nonenrollees; Patient participants; Randomized clinical trials; Trial participants

Indexed keywords

ANTIARRHYTHMIC AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; HEART ARRHYTHMIA; HUMAN; MORTALITY; PATIENT; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 0038030987     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(03)00002-3     Document Type: Article

References (22)

1. Valentino J., Andrykowski M.A., Wood T.A. Population attitudes toward oncology clinical trials. J Ky Med Assoc. 97:1999;111-117.
2. Weijer C. The revolution in clinical trials: from burden to benefit and back again. Future Health [quarterly, Canadians for Health Research (CHR)]. Winter:1994.
3. Wilson T. Experts still see syphilis study's taint - many blacks distrust medicine, they say. Chicago Tribune. July 2, 1997;3.
4. National Institutes of Health Guide: Findings of Scientific Misconduct. Volume 24:(Number 25):July 14, 1995.
5. Nelson D., Weiss R. Earlier gene test deaths not reported: NIH was unaware of "adverse events." Washington Post. January 31, 2000;A1.
6. Steinbrook R. Protecting research subjects - the crisis at Johns Hopkins. N Engl J Med. 346:2002;716-720.
7. Tangrea J.A., Adrianza M.E., Helsel W.E. Patients' perceptions on participation in a cancer chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 1:1992;325-330.
8. Bevan E.G., Chee L.C., McGhee S.M., McInnes G.T. Patients' attitudes to participation in clinical trials. Br J Clin Pharmacol. 35:1993;204-207.
9. Verheggen F.W., Nieman F.H., Reerink E., Kok G.J. Patient satisfaction with clinical trial participation. Int J Qual Health Care. 10:1998;319-330.
10. Wilcox M., Schroer S. The perspective of patients with vascular disease on participation in clinical trials. J Vasc Nurs. 12:1994;112-116.
11. Mattson M.E., Curb J.D., McArdle R. Participation in a clinical trial: the patients' point of view. Control Clin Trials. 6:1985;156-167.
12. Henzlova M.J., Blackburn G.H., Bradley E.J., Rogers W.J. Patient perception of a long-term clinical trial: experience using a close-out questionnaire in the Studies of Left Ventricular Dysfunction (SOLVD) Trial. SOLVD Close-out Working Group. Control Clin Trials. 15:1994;284-293.
13. Schron E.B., Wassertheil-Smoller S., Pressel S. Clinical trial participant satisfaction: survey of SHEP enrollees. SHEP Cooperative Research Group. Systolic Hypertension in the Elderly Program. J Am Geriatr Soc. 45:1997;934-938.
14. Braunholtz D.A., Edwards S.J., Lilford R.J. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol. 54:2001;217-224.
15. National Death Index User's Manual. U.S. Dept of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics: DHHS Pub No. (PHS) 90-1148. September, 1990.
16. Gorkin L., Schron E.B., Handshaw K., et al. Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Control Clin Trials. 17:1996;46-59.
17. Kim S.G., Hallstrom A., Love J.C., et al. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) trial and nonrandomized registry patients. Am J Cardiol. 80:1997;454-457.
18. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 321:1989;406-412.
19. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 327:1992;227-233.
20. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
21. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data. 1980;John Wiley & Sons, Inc, New York.
22. Domanski M.J., Sakseena S., Epstein A.E., et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol. 34:1999;1090-1095.